D-0113-2018 Class I Terminated

Recalled by Advanced Pharma Inc. — Houston, TX

FDA drug recall D-0113-2018 was initiated by Advanced Pharma Inc. on Jun 9, 2017 and is designated Class I. Reason for recall: Subpotent Drug: found to be below the specification for labeled assay. The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 550 syringes.

Recall details

Product Type
Drugs
Report Date
Dec 27, 2017
Initiation Date
Jun 9, 2017
Termination Date
Apr 3, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
550 syringes

Product description

NitroGlycerin 1 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (100 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-818-61.

Reason for recall

Subpotent Drug: found to be below the specification for labeled assay.

Distribution pattern

Nationwide in the USA to hospitals and medical facilities.

Code information

Lot: 4/17/17 0857 81861S, BUD 08/15/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0113-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0113-2018. Report a data issue: hello@regdatalab.com.